Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alferon LDO in Symptomatic HIV+ Subjects
NCT00002018Phase 2Completed
- Sponsor
- Interferon Sciences, Inc.
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-n3 in human immunodeficiency virus infection (HIV), sponsored by Interferon Sciences, Inc.. Status: completed.
02
Drugs
interferon alfa-n3
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002018.